Amyloid-β (Aβ) deposition as seen on PET using an Aβ-binding agent is a critical diagnostic biomarker for Alzheimer disease (AD). Some reports suggest using white matter (WM) as a reference region for quantification of serial Aβ PET studies; however, nonspecific WM retention in Aβ PET in people with dementia or cognitively unimpaired (CU) has been widely reported and is poorly understood. Methods: To investigate the suitability of WM as a reference region and the factors affecting WM 11C-Pittsburgh compound B (11C-PiB) uptake variability, we conducted a retrospective study on 2 large datasets: a longitudinal study of participants (n = 577) who were CU, had mild cognitive impairment, or had dementia likely due to AD; and a cross-sectional study of single-scan PET imaging in CU subjects (n = 1,349). In the longitudinal study, annual changes in WM 11C-PiB uptake were assessed, and in the cross-sectional study, WM 11C-PiB uptake was assessed relative to subject age. Results: Overall, we found that WM 11C-PiB uptake showed age-related increases, which varied with the WM regions selected. Further, variable annual WM 11C-PiB uptake changes were seen with different gray matter (GM) 11C-PiB baseline uptake levels. Conclusion: WM binding increases with age and varies with GM 11C-PiB. These correlations should be considered when using WM for normalization in 11C-PiB PET studies. The cerebellar crus1+crus2 showed no increase with age and cerebellar GM+WM showed minimal increase, supporting their use as reference regions for cross-sectional studies comparing wide age spans. In longitudinal studies, the increase in WM uptake may be minimal in the short-term and thus using WM as a reference region in these studies seems reasonable. However, as participants age, the findings may be affected by changes in WM uptake. Changes in WM 11C-PiB uptake may relate to disease progression, warranting examination of the causes of WM 11C-PiB uptake.
Amyloid-β (Aβ) deposition as seen on PET using an Aβ-binding agent is a critical diagnostic biomarker for Alzheimer disease (AD). Some reports suggest using white matter (WM) as a reference region for quantification of serial Aβ PET studies; however, nonspecific WM retention in Aβ PET in people with dementia or cognitively unimpaired (CU) has been widely reported and is poorly understood. Methods: To investigate the suitability of WM as a reference region and the factors affecting WM 11C-Pittsburgh compound B (11C-PiB) uptake variability, we conducted a retrospective study on 2 large datasets: a longitudinal study of participants (n = 577) who were CU, had mild cognitive impairment, or had dementia likely due to AD; and a cross-sectional study of single-scan PET imaging in CU subjects (n = 1,349). In the longitudinal study, annual changes in WM 11C-PiB uptake were assessed, and in the cross-sectional study, WM 11C-PiB uptake was assessed relative to subject age. Results: Overall, we found that WM 11C-PiB uptake showed age-related increases, which varied with the WM regions selected. Further, variable annual WM 11C-PiB uptake changes were seen with different gray matter (GM) 11C-PiB baseline uptake levels. Conclusion: WM binding increases with age and varies with GM 11C-PiB. These correlations should be considered when using WM for normalization in 11C-PiB PET studies. The cerebellar crus1+crus2 showed no increase with age and cerebellar GM+WM showed minimal increase, supporting their use as reference regions for cross-sectional studies comparing wide age spans. In longitudinal studies, the increase in WM uptake may be minimal in the short-term and thus using WM as a reference region in these studies seems reasonable. However, as participants age, the findings may be affected by changes in WM uptake. Changes in WM 11C-PiB uptake may relate to disease progression, warranting examination of the causes of WM 11C-PiB uptake.
Authors: Mark E Schmidt; Ping Chiao; Gregory Klein; Dawn Matthews; Lennart Thurfjell; Patricia E Cole; Richard Margolin; Susan Landau; Norman L Foster; N Scott Mason; Susan De Santi; Joyce Suhy; Robert A Koeppe; William Jagust Journal: Alzheimers Dement Date: 2014-11-24 Impact factor: 21.566
Authors: Burcu Zeydan; Val J Lowe; Christopher G Schwarz; Scott A Przybelski; Nirubol Tosakulwong; Samantha M Zuk; Matthew L Senjem; Jeffrey L Gunter; Rosebud O Roberts; Michelle M Mielke; Eduardo E Benarroch; Moses Rodriguez; Mary M Machulda; Timothy G Lesnick; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci; Orhun H Kantarci Journal: Mult Scler Date: 2017-05-05 Impact factor: 6.312
Authors: Rik Vandenberghe; Koen Van Laere; Adrian Ivanoiu; Eric Salmon; Christine Bastin; Eric Triau; Steen Hasselbalch; Ian Law; Allan Andersen; Alex Korner; Lennart Minthon; Gaëtan Garraux; Natalie Nelissen; Guy Bormans; Chris Buckley; Rikard Owenius; Lennart Thurfjell; Gill Farrar; David J Brooks Journal: Ann Neurol Date: 2010-09 Impact factor: 10.422
Authors: Victor L Villemagne; Rachel S Mulligan; Svetlana Pejoska; Kevin Ong; Gareth Jones; Graeme O'Keefe; J Gordon Chan; Kenneth Young; Henri Tochon-Danguy; Colin L Masters; Christopher C Rowe Journal: Eur J Nucl Med Mol Imaging Date: 2012-03-08 Impact factor: 9.236
Authors: William E Klunk; Robert A Koeppe; Julie C Price; Tammie L Benzinger; Michael D Devous; William J Jagust; Keith A Johnson; Chester A Mathis; Davneet Minhas; Michael J Pontecorvo; Christopher C Rowe; Daniel M Skovronsky; Mark A Mintun Journal: Alzheimers Dement Date: 2014-10-28 Impact factor: 21.566
Authors: Timo Grimmer; Maximilian Faust; Florian Auer; Panagiotis Alexopoulos; Hans Förstl; Gjermund Henriksen; Robert Perneczky; Christian Sorg; Behrooz H Yousefi; Alexander Drzezga; Alexander Kurz Journal: Neurobiol Aging Date: 2012-03-10 Impact factor: 4.673
Authors: Rebecca L McNamee; Seong-Hwan Yee; Julie C Price; William E Klunk; Bedda Rosario; Lisa Weissfeld; Scott Ziolko; Michael Berginc; Brian Lopresti; Steven Dekosky; Chester A Mathis Journal: J Nucl Med Date: 2009-02-17 Impact factor: 10.057
Authors: Burcu Zeydan; Christopher G Schwarz; Scott A Przybelski; Timothy G Lesnick; Walter K Kremers; Matthew L Senjem; Orhun H Kantarci; Paul H Min; Bradley J Kemp; Clifford R Jack; Kejal Kantarci; Val J Lowe Journal: J Nucl Med Date: 2021-12-16 Impact factor: 11.082
Authors: Tomotaka Tanaka; Mary C Stephenson; Ying-Hwey Nai; Damian Khor; Francis N Saridin; Saima Hilal; Steven Villaraza; Bibek Gyanwali; Masafumi Ihara; Henri Vrooman; Ashley A Weekes; John J Totman; Edward G Robins; Christopher P Chen; Anthonin Reilhac Journal: Eur J Nucl Med Mol Imaging Date: 2019-12-20 Impact factor: 9.236
Authors: Pawel J Markiewicz; Julian C Matthews; John Ashburner; David M Cash; David L Thomas; Enrico De Vita; Anna Barnes; M Jorge Cardoso; Marc Modat; Richard Brown; Kris Thielemans; Casper da Costa-Luis; Isadora Lopes Alves; Juan Domingo Gispert; Mark E Schmidt; Paul Marsden; Alexander Hammers; Sebastien Ourselin; Frederik Barkhof Journal: Neuroimage Date: 2021-02-12 Impact factor: 6.556
Authors: Julie Ottoy; Ellis Niemantsverdriet; Jeroen Verhaeghe; Ellen De Roeck; Hanne Struyfs; Charisse Somers; Leonie Wyffels; Sarah Ceyssens; Sara Van Mossevelde; Tobi Van den Bossche; Christine Van Broeckhoven; Annemie Ribbens; Maria Bjerke; Sigrid Stroobants; Sebastiaan Engelborghs; Steven Staelens Journal: Neuroimage Clin Date: 2019-03-13 Impact factor: 4.881
Authors: Burcu Zeydan; Christopher G Schwarz; Val J Lowe; Robert I Reid; Scott A Przybelski; Timothy G Lesnick; Walter K Kremers; Matthew L Senjem; Jeffrey L Gunter; Hoon-Ki Min; Prashanthi Vemuri; David S Knopman; Ronald C Petersen; Clifford R Jack; Orhun H Kantarci; Kejal Kantarci Journal: Ann Clin Transl Neurol Date: 2019-03-03 Impact factor: 4.511
Authors: Yi Su; Shaney Flores; Guoqiao Wang; Russ C Hornbeck; Benjamin Speidel; Nelly Joseph-Mathurin; Andrei G Vlassenko; Brian A Gordon; Robert A Koeppe; William E Klunk; Clifford R Jack; Martin R Farlow; Stephen Salloway; Barbara J Snider; Sarah B Berman; Erik D Roberson; Jared Brosch; Ivonne Jimenez-Velazques; Christopher H van Dyck; Douglas Galasko; Shauna H Yuan; Suman Jayadev; Lawrence S Honig; Serge Gauthier; Ging-Yuek R Hsiung; Mario Masellis; William S Brooks; Michael Fulham; Roger Clarnette; Colin L Masters; David Wallon; Didier Hannequin; Bruno Dubois; Jeremie Pariente; Raquel Sanchez-Valle; Catherine Mummery; John M Ringman; Michel Bottlaender; Gregory Klein; Smiljana Milosavljevic-Ristic; Eric McDade; Chengjie Xiong; John C Morris; Randall J Bateman; Tammie L S Benzinger Journal: Alzheimers Dement (Amst) Date: 2019-02-22
Authors: Francisco Javier López-González; Alexis Moscoso; Nikos Efthimiou; Anxo Fernández-Ferreiro; Manuel Piñeiro-Fiel; Stephen J Archibald; Pablo Aguiar; Jesús Silva-Rodríguez Journal: EJNMMI Phys Date: 2019-12-19
Authors: Christina B Young; Susan M Landau; Theresa M Harrison; Kathleen L Poston; Elizabeth C Mormino Journal: Neuroimage Date: 2021-09-03 Impact factor: 6.556
Authors: Stefan J Teipel; Martin Dyrba; Andrea Vergallo; Simone Lista; Marie Odile Habert; Marie-Claude Potier; Foudil Lamari; Bruno Dubois; Harald Hampel; Michel J Grothe Journal: Front Aging Neurosci Date: 2021-12-22 Impact factor: 5.750
Authors: Nelly Joseph-Mathurin; Namita Sinha; Aihong Zhou; Nigel J Cairns; Tammie L S Benzinger; Charles D Chen; Yan Li; Karl Friedrichsen; Austin McCullough; Erin E Franklin; Russ Hornbeck; Brian Gordon; Vijay Sharma; Carlos Cruchaga; Alison Goate; Celeste Karch; Eric McDade; Chengjie Xiong; Randall J Bateman; Bernardino Ghetti; John M Ringman; Jasmeer Chhatwal; Colin L Masters; Catriona McLean; Tammaryn Lashley; Yi Su; Robert Koeppe; Clifford Jack; William E Klunk; John C Morris; Richard J Perrin Journal: Acta Neuropathol Date: 2021-07-28 Impact factor: 15.887